Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Cases (5)
-
December 20, 2021
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al
835(Patent - Abbreviated New Drug Applications (ANDA)) | West Virginia Northern
-
March 31, 2020
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
-
March 27, 2020
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware | Multi-district Litigation
- 2 additional result(s)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- Full-text search of patent complaints
- Full-text search of PTAB cases and documents
- Database of TTAB cases and documents, including full-text search of documents
- Customized email alerts and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View full search results
Already a subscriber? Click here to login